ganciclovir |
82410-32-0 |
Cytovene |
Gancyclovir |
Vitrasert |
Zirgan |
RS-21592 |
Ganciclovirum |
Cymevene |
2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one |
BW-759U |
Virgan |
2-Nor-2-deoxyguanosine |
BW 759U |
2-NDG |
BW 759 |
9-(1,3-Dihydroxy-2-propoxy)methylguanine |
UNII-P9G3CKZ4P5 |
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine |
MFCD00870588 |
9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE |
GA2 |
CHEBI:465284 |
2-amino-9-{(1,3-dihydroxypropan-2-yl)oxymethyl}-6,9-dihydro-3H-purin-6-one |
9-((1,3-Dihydroxy-2-propoxy)methyl)guanine |
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- |
Hydroxyacyclovir |
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one |
P9G3CKZ4P5 |
2-amino-9-{(1,3-dihydroxypropan-2-yl)oxymethyl}-1,9-dihydro-6H-purin-6-one |
MLS000028481 |
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol |
NCGC00015471-02 |
2-(2-amino-6-hydroxypurin-9-yl)methoxypropane-1,3-diol |
HHEMG |
SMR000058324 |
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one |
Biolf 62 |
Ganciclovirum Latin |
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol |
CAS-82410-32-0 |
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one |
2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one |
2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone |
DSSTox_CID_21032 |
DSSTox_RID_79613 |
DSSTox_GSID_41032 |
GCV |
BIOLF-62 |
9-2-Hydroxy-1-(hydroxymethyl)ethoxymethylguanine |
Citovirax |
Cymevan |
Cymeven |
BW-B 759U |
2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol |
DRG-0018 |
2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1,9-dihydro-6H-purin-6-one |
Vitrasert (TN) |
Cytovene (TN) |
CCRIS 9212 |
HSDB 6512 |
SR-01000075894 |
GCV & MSL |
Ganciclovir (JAN/USP/INN) |
2-amino-9-2-hydroxy-1-(hydroxymethyl)ethoxymethyl-1H-purin-6-one |
Ganciclovir,(S) |
2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one |
BW-795 |
MB3795 |
Prestwick_1068 |
ST-605 |
Zirgan (TN) |
6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- |
GCV & 1110U81 |
Ganciclovir USAN:USP:INN:BAN:JAN |
Opera_ID_284 |
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one |
Prestwick0_000839 |
Prestwick1_000839 |
Prestwick2_000839 |
Prestwick3_000839 |
Lopac-G-2536 |
BIOLF62 |
CHEMBL182 |
EC 627-054-3 |
G 2536 |
SCHEMBL3033 |
Lopac0_000539 |
BSPBio_000797 |
MLS001077349 |
BIDD:GT0783 |
SPBio_002718 |
BPBio1_000877 |
ZINC1505 |
DTXSID8041032 |
methyl)-1H-purin-6(9H)-one |
SCHEMBL14491348 |
BDBM85707 |
HMS1570H19 |
HMS2090K08 |
HMS2097H19 |
HMS2235C21 |
HMS3259B13 |
HMS3261L19 |
HMS3371H01 |
HMS3604L19 |
HMS3655M18 |
HMS3714H19 |
Pharmakon1600-01502362 |
ACT03317 |
BCP12705 |
NSC_3454 |
Tox21_110160 |
Tox21_500539 |
BBL029078 |
BDBM50237614 |
NSC759656 |
PDSP1_000816 |
PDSP2_000803 |
s1878 |
SBB066292 |
STK801910 |
STL514515 |
2-amino-9-2-hydroxy-1-(hydroxymethyl)ethoxymethyl-3H-purin-6-one |
AKOS004119898 |
AKOS026749928 |
AKOS037492029 |
Tox21_110160_1 |
Valganciclovir hydrochloride impurity a |
AC-8069 |
CCG-204629 |
CS-2014 |
DB01004 |
Ganciclovir, >=99% (HPLC), powder |
KS-1065 |
LP00539 |
MCULE-9512761592 |
NC00647 |
NSC 759656 |
NSC-759656 |
SDCCGSBI-0050522.P002 |
2-Amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6H-purin-6-one |
SMP2_000038 |
NCGC00015471-01 |
NCGC00015471-03 |
NCGC00015471-04 |
NCGC00015471-05 |
NCGC00015471-06 |
NCGC00015471-08 |
NCGC00015471-16 |
NCGC00093928-01 |
NCGC00093928-02 |
NCGC00168567-01 |
NCGC00188980-01 |
NCGC00261224-01 |
9-(1,3-dihydroxy-2propoxymethyl)guanine |
BG164496 |
HY-13637 |
SY027981 |
9-(1,3-dihydroxy-2-propoxymethyl)guanine |
AB0012496 |
CAS_82410-32-0 |
2-amino-9-((1,3-dihydroxypropan-2-yloxy) |
9-(1,3-dihydroxy-2-propoxymethyl)-guanine |
EU-0100539 |
FT-0611007 |
FT-0668948 |
G0315 |
SW197135-3 |
EN300-49857 |
C07019 |
D00333 |
J10127 |
40034-EP2377510A1 |
Ganciclovir 100 microg/mL in Acetonitrile:Water |
410G320 |
9-(1,3-Dihydroxy-2-propyl)oxymethylguanine |
A840322 |
A935676 |
Ganciclovir, Antibiotic for Culture Media Use Only |
Q417640 |
SR-01000721941 |
Q-201148 |
SR-01000075894-1 |
SR-01000075894-4 |
SR-01000721941-3 |
Z1259084907 |
Ganciclovir, European Pharmacopoeia (EP) Reference Standard |
2-(2-amino-6-hydroxy-9H-purin-9-yl)methoxypropane-1,3-diol |
Ganciclovir, United States Pharmacopeia (USP) Reference Standard |
2-amino-9-{2-hydroxy-1-(hydroxymethyl)ethoxymethyl}hydropurin-6-one |
Ganciclovir, Pharmaceutical Secondary Standard; Certified Reference Material |
2-((6-Hydroxy-2-imino-2,3-dihydro-9H-purin-9-yl)methoxy)propane-1,3-diol |
2-amino-9-{2-hydroxy-1-(hydroxymethyl)ethoxymethyl}-1,9-dihydro-6H-purin-6-one |
Ganciclovir, 1.0 mg/mL (1% 1M HCl in Methanol), certified reference material |
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody |